Increasing prevalence of infertility and growing awareness about single parenthood and same-sex parenthoods is anticipated to boost the Home Insemination market during the forecast period 2021-2026. Home Insemination Market size is forecast to reach $171.82 million by 2026, growing at a CAGR of 3.7% during the period 2021-2026.
The Home Insemination market is growing at a significant rate as medical device manufacturers are making substantial improvements toward safer home insemination products. Most people undergo home insemination procedures under the guidance of their gynecologist, who generally has a good amount of experience regarding it. Home insemination is a type of artificial insemination carried out inside the comfort of one's own home. It is often beneficial for heterosexual couples who want to improve their chances of pregnancy.
Infertility is common in developed countries. Out of 100 couples within the U.S., about 12 to 13 of them have trouble becoming pregnant. About ten in 100 (6.1 million) women within the U.S. aged 26–40 have difficulty becoming pregnant or staying pregnant, consistent with the Centers for Disease Control and Prevention. Some people are completely sub-fertile, infertile, and unexplained infertility. Most of the couples experience difficulties while first trying to conceive. These peoples prefer home insemination before turning to In-Vitro Fertilization (IVF) procedure. Home insemination procedure is completed reception by using an insemination kit that has semen containers, ovulation tests, syringes, and other items to assist conception. Some kits include ovulation predictor kits since the technique time is time important to support the feminine cycle. Insemination reception has several advantages like the involvement of partners, relaxed environment, use of fresh sperm, high pregnancy rates, and low cost for the procedure. Conceivex announced that its signature product, The Conception Kit® at-home system, an FDA cleared, affordable at-home treatment for infertility would be available through a replacement partnership with online and mail-order pharmacy HealthWarehouse.com. Conceivex and Health Warehouse had signed a National contract for the product’s sales expansion.
North America dominated the global market share of home insemination in 2020 owing to the growing demand for Home Insemination by single mothers & lesbian couples and the increasing prevalence of infertility among adults. The growing trend towards innovations in-home insemination is owing to technological advancements, favorable rules, and regulations. A large population base, improving healthcare infrastructure, growing medical tourism, and rising disposable incomes within the region are expected to supply significant growth opportunities for key players operating in the market. Regulatory agencies such as the Food and Drug Administration (FDA), International Organization for Standardization (ISO), and Clinical and Laboratory Standard Institutes (CLSI) enforce guidelines that ensure the home insemination products are consistent in both design and manufacture. All these factors are set to avail new growth opportunities to the home insemination market in the region during 2021-2026.
Talk to one of our sales representative about the full report by providing your details in the link below:
Home Insemination Market Growth Drivers:
Increasing Demand for Intracervical Insemination
Intracervical insemination (ICI) is a great first step for many couples who want to do all they can on their own before moving on to fertility treatments. With ICI, one can give sperm a little jump start, by using a syringe, like Mosie, to deliver the sample right at or near the cervical opening. Intracervical insemination is the simplest and least expensive than other techniques. Also, the emerging trend of delayed pregnancies among women, and the surge in health-care spending and disposable income has significantly contributed to the growth of the global home insemination market.
Increasing Advancements in Technology of Fertility Treatment
Infertility is mainly owing to a different gynecological disorder like ovulation disorder, fallopian tube damage, hormonal problems, cervical issues, and polycystic ovary syndrome including many health issues that can also lead to infertility. In the three-parent embryos technique, part of the eggs from two women is taken and fertilized in a man’s sperm. Young men and ladies can freeze their eggs ad sperms for later use. This is set to give a boost in the home insemination market in upcoming years.
In May 2018, Conceivex Inc., a privately held medical device company partnered with Zackslnvesr to drive the roll out of the conception kits at-home system.
The Major Players in this Market Include
The major companies in the Home Insemination Market include Rinovum Women’s Health, LLC, Pride Angel, Hi-Tech Solutions, Kitazato Corp., Rocket Medical plc., Conception Kit Company, Conceivex, Inc., Labotech GmbH, Hamilton Thorn Ltd. and Zander scientific Inc. among others. In August 2015, The Stork OTC home conception aid in Australia was launched by Rinovum Women’s Health Company.
Over the years, major market players have focused on needle and syringes which were typically used in home insemination. Launch of new market companies, adequate funding, and government-aided policies help in the development of home insemination products. The continuous developments in the Home Insemination Market such as advanced technologies, increasing funding amount of startups and research organizations, and surge in the number of product and home insemination products approvals by Food and Drug Administration (FDA) are the major factors set to drive the Home Insemination market during the forecast period 2021-2026.
To request for a quote, provide your details in the below link:
Mr. Venkat Reddy
Email: [email protected]
Contact Sales: +1-970-236-3677
About IndustryARC: IndustryARC is a Research and Consulting Firm that publishes more than 500 reports annually, in various industries such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food and Beverages, Information Technology, and Life sciences and Healthcare.